The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists

KA Yonkers, KL Wisner, DE Stewart… - General hospital …, 2009 - Elsevier
OBJECTIVE: To address the maternal and neonatal risks of both depression and
antidepressant exposure and develop algorithms for periconceptional and antenatal …

Selected pregnancy and delivery outcomes after exposure to antidepressant medication: a systematic review and meta-analysis

LE Ross, S Grigoriadis, L Mamisashvili… - JAMA …, 2013 - jamanetwork.com
Importance Untreated depression during pregnancy has been associated with increased
morbidity and mortality for both mother and child and, as such, optimal treatment strategies …

Selective serotonin-reuptake inhibitors and risk of persistent pulmonary hypertension of the newborn

CD Chambers, S Hernandez-Diaz… - … England Journal of …, 2006 - Mass Medical Soc
Background Persistent pulmonary hypertension of the newborn (PPHN) is associated with
substantial infant mortality and morbidity. A previous cohort study suggested a possible …

Neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitor antidepressants and maternal depression using population-based linked health …

TF Oberlander, W Warburton, S Misri… - Archives of general …, 2006 - jamanetwork.com
Context Prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants
and maternal depression both alter neonatal health, and distinguishing the effects of each …

Major depression and antidepressant treatment: impact on pregnancy and neonatal outcomes

KL Wisner, DKY Sit, BH Hanusa… - American Journal of …, 2009 - Am Psychiatric Assoc
Objective: Selective serotonin reuptake inhibitor (SSRI) use during pregnancy incurs a low
absolute risk for major malformations; however, other adverse outcomes have been …

Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data

M Reis, B Källén - Psychological medicine, 2010 - cambridge.org
BackgroundConcerns have been expressed about possible adverse effects of the use of
antidepressant medication during pregnancy, including risk for neonatal pathology and the …

Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications

EL Moses-Kolko, D Bogen, J Perel, A Bregar, K Uhl… - Jama, 2005 - jamanetwork.com
ContextA neonatal behavioral syndrome linked to in utero serotonin reuptake inhibitor (SRI)
exposure during the last trimester of pregnancy has been identified. The US Food and Drug …

Depression during pregnancy

DE Stewart - New England Journal of Medicine, 2011 - Mass Medical Soc
Key Clinical Points Depression During Pregnancy Major depression is a disabling, treatable
disorder that affects more than 12% of pregnant women. Untreated depression during …

Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants

R Levinson-Castiel, P Merlob, N Linder… - … of pediatrics & …, 2006 - jamanetwork.com
Objective To compare the prevalence and clinical characteristics of neonatal abstinence
syndrome in neonates exposed and not exposed to selective serotonin reuptake inhibitors …

BSR and BHPR guideline on prescribing drugs in pregnancy and breastfeeding—Part II: analgesics and other drugs used in rheumatology practice

J Flint, S Panchal, A Hurrell, M van de Venne… - …, 2016 - academic.oup.com
Julia Flint1, Sonia Panchal2, Alice Hurrell3, Maud van de Venne4, Mary Gayed5, Karen
Schreiber6, 7, Subha Arthanari8, Joel Cunningham3, Lucy Flanders3, Louise Moore9, Amy …